After two months of using ColonBroom GLP-1 Booster, she shared that she felt fuller after lunch, no longer reached for candy at 3 p.m., and noticed steady afternoon energy
Constipation is one of the most common reasons patients discontinue GLP-1 therapy, yet it remains preventable and manageable with foresight
The Evolution of GLP-1 Weight Loss Shots The story of GLP-1 weight loss shots actually began with diabetes treatment, not weight management
GIP, or glucose-dependent insulinotropic polypeptide, works alongside GLP-1
BPC-157 does not cause traditional tolerance as it is non-hormonal, does not suppress natural production, requires no post-cycle therapy, and shows no rebound effects
Three case reports from the World Health Organization (WHO) adverse drug reaction database describe increased toxicity in patients taking ginger and cancer medications that are CYP3A4 substrates (imatinib, dabrafenib, and crizotinib)